TY - JOUR
T1 - Posterior Reversible Encephalopathy Syndrome in Children
T2 - Its High Prevalence and More Extensive Imaging Findings
AU - Ishikura, Kenji
AU - Ikeda, Masahiro
AU - Hamasaki, Yuko
AU - Hataya, Hiroshi
AU - Shishido, Seiichirou
AU - Asanuma, Hiroshi
AU - Nishimura, Gen
AU - Hiramoto, Ryugo
AU - Honda, Masataka
PY - 2006/8
Y1 - 2006/8
N2 - Background: Posterior reversible encephalopathy syndrome is a distinctive clinicoradiological entity observed in a variety of clinical settings, including pediatric patients. A greater prevalence of this syndrome has been suggested in kidney transplant recipients and patients with kidney disease. Although usually considered benign and reversible, characteristics of this syndrome in pediatric patients remain obscure. The objective of the present study involved disclosing details of imaging findings, as well as the clinical course and prevalence of the syndrome in this field. Methods: We investigated kidney transplant recipients and pediatric patients with kidney disease in our institution from 1990 to 2004. For these patients, clinical course, imaging findings, blood pressure, concurrent medical illnesses, and administrative condition of calcineurin inhibitors were analyzed. Results: Twenty cases of posterior reversible encephalopathy syndrome were investigated in patients ranging in age from 1.9 to 18.3 years. In most patients, radiological abnormalities extended to the gray matter (17 of 20 patients), frontal and temporal lobes, and even the cerebellum (16 patients). Of 177 kidney transplant recipients (cyclosporine, 127 patients; tacrolimus, 50 patients), 6 patients administered cyclosporine (4.7%) and 4 patients administered tacrolimus (8.0%) developed the syndrome after transplantation. Conclusion: Posterior reversible encephalopathy syndrome should be suspected in pediatric kidney transplant recipients and patients with kidney disease if they have a sudden episode of neurological symptoms, even if imaging findings are not restricted to the subcortical white matter of the occipital region.
AB - Background: Posterior reversible encephalopathy syndrome is a distinctive clinicoradiological entity observed in a variety of clinical settings, including pediatric patients. A greater prevalence of this syndrome has been suggested in kidney transplant recipients and patients with kidney disease. Although usually considered benign and reversible, characteristics of this syndrome in pediatric patients remain obscure. The objective of the present study involved disclosing details of imaging findings, as well as the clinical course and prevalence of the syndrome in this field. Methods: We investigated kidney transplant recipients and pediatric patients with kidney disease in our institution from 1990 to 2004. For these patients, clinical course, imaging findings, blood pressure, concurrent medical illnesses, and administrative condition of calcineurin inhibitors were analyzed. Results: Twenty cases of posterior reversible encephalopathy syndrome were investigated in patients ranging in age from 1.9 to 18.3 years. In most patients, radiological abnormalities extended to the gray matter (17 of 20 patients), frontal and temporal lobes, and even the cerebellum (16 patients). Of 177 kidney transplant recipients (cyclosporine, 127 patients; tacrolimus, 50 patients), 6 patients administered cyclosporine (4.7%) and 4 patients administered tacrolimus (8.0%) developed the syndrome after transplantation. Conclusion: Posterior reversible encephalopathy syndrome should be suspected in pediatric kidney transplant recipients and patients with kidney disease if they have a sudden episode of neurological symptoms, even if imaging findings are not restricted to the subcortical white matter of the occipital region.
KW - Posterior reversible encephalopathy syndrome
KW - calcineurin inhibitor
KW - hypertension
KW - kidney disease
KW - kidney transplantation
KW - pediatric patient
UR - http://www.scopus.com/inward/record.url?scp=33745951512&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745951512&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2006.04.076
DO - 10.1053/j.ajkd.2006.04.076
M3 - Article
C2 - 16860188
AN - SCOPUS:33745951512
SN - 0272-6386
VL - 48
SP - 231
EP - 238
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 2
ER -